Daré Bioscience Inc. (DARE) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Daré Bioscience Inc.

NASDAQ: DARE · Real-Time Price · USD
2.08
0.02 (0.97%)
At close: Aug 21, 2025, 2:48 PM

Daré Bioscience Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-18.6M -21.34M -23.72M -23.27M -26.87M -28.87M -30.16M -41.05M -39.77M -30.59M -30.95M -24.55M -30.19M -39.77M -38.7M -37.6M -32.51M -30.47M
Depreciation & Amortization
634.29K 185K 37.67K 41.28K 40.8K 39.63K 38.36K 39.01K 32.78K 28.48K 24.2K 20.63K 23.94K 25.23K 26.41K 26.16K 32.32K 37.69K
Stock-Based Compensation
1.69M 1.96M 2.21M 2.34M 2.51M 2.53M 2.53M 2.44M 2.36M 2.25M 2.16M 2.02M 1.9M 1.77M 1.6M 1.41M 1.17M 947.1K
Other Working Capital
3.86M 4.41M 4.54M -7.18M -4.83M -5.43M -12.49M 899.4K 12.59M 7.2M 10.77M -2.42M -2.02M 3.93M 7.65M 9.5M -1.42M 3.03M
Other Non-Cash Items
849.09K 1.83M 2.5M 4.41M 4.39M 3.15M 2.44M 276.55K 51.03K 76.64K -23.06K -43.93K 3.36K -37.38K -51.85K -61.72K -117.36K -130.6K
Deferred Income Tax
n/a n/a n/a -2.06M -2.06M -2.06M -2.06M n/a n/a n/a n/a n/a n/a n/a -369.89K -369.89K -369.89K -369.89K
Change in Working Capital
3.84M 4.81M 5.07M -8.77M -7.37M -4.34M -11.64M 1.71M 17.32M 6.37M 10.7M 447.26K -1.12M 5.29M 8.73M 8.55M -2.92M 2.97M
Operating Cash Flow
-11.59M -12.99M -14.33M -27.74M -29.79M -29.55M -38.86M -36.57M -20M -21.86M -18.09M -22.11M -29.39M -32.73M -28.76M -28.04M -34.72M -27.01M
Capital Expenditures
-284.46K -445.15K -295.12K -339.6K -644.02K -636.73K -629.43K -24.8K -57.7K -58.52K -63.07K -14.58M -14.54M -14.54M -14.54M -16.9K -2.38K -17.63K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 925M 925M 925M 925M n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -924.99M -924.99M -924.99M -924.99M n/a n/a n/a
Investing Cash Flow
-284.46K -445.15K -295.12K -339.6K -644.02K -636.73K -629.43K -24.8K -57.7K -58.52K -63.07K -14.57M -14.53M -14.53M -14.52M -16.9K -2.38K -17.63K
Debt Repayment
-458.85K -137.98K -151.15K -164.32K -133.59K 66.8K 267.19K 467.58K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -6.86M -6.86M -6.86M
Other Financial Acitivies
-684 -3.82K -2.06K 4.72M 4.72M 4.72M 6.02M 1.3M 1.3M 1.42M 124.61K 402.41K 602.42K 482.27K 532.67K 7.12M 7.03M 11.42M
Financial Cash Flow
507.21K 572.72K 340.17K 5.78M 13.92M 14.35M 15.64M 10.33M 1.76M 2.64M 1.34M 17.35M 52.56M 64.47M 75.85M 68.3M 38.48M 29.62M
Net Cash Flow
-11.38M -12.93M -14.41M -22.29M -16.54M -15.86M -23.86M -26.16M -18.41M -19.49M -17M -5.18M 22.96M 31.66M 47M 40.18M 3.76M 2.61M
Free Cash Flow
-11.87M -13.43M -14.63M -28.08M -30.43M -30.19M -39.49M -36.6M -20.06M -21.92M -18.15M -36.69M -43.93M -47.27M -43.3M -28.06M -34.72M -27.03M